First hand experience which sits in agreeance with my earlier statement, the low number likely due to only a few people able to prescribe and get it for patients. I wasn't trying to cause panic, to the contrary I thought the 62 bottles sold so far was good for the first quarterly to involve numbers from it. this is child's play compared to when (IMHO) FDA approval lands, but I personally think it being prescribed under TGA will tremendously help word of mouth spread so that it can fullfill its potential when it's fully approved to be prescribed by any doctor.
LTP Price at posting:
$1.25 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)